JournalQ2· SCImago 2025
BMC Cancer
ISSN 1471-2407
- Q2Quartile
- 1.00SJR
- 180h-index
- 3papers summarised
About this journal
BMC Cancer is a Q2 journal by SCImago Journal Rank (2025 data), with an SJR of 1.00 and an h-index of 180. Most of its papers in the Pofolia pool fall under Hematology. Pofolia holds AI summaries of 3 paper(s) from this journal; the most cited is “Belantamab mafodotin plus venetoclax in t(11;14)-positive relapsed or refractory multiple…” (0 citations).
The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal?
Papers we summarise from this journal
- Belantamab mafodotin plus venetoclax in t(11;14)-positive relapsed or refractory multiple myeloma – the BELI(E)VE trial2026 · 0 citations
- Induction failure and early death in paediatric acute myeloid leukaemia in Uganda: a developing country experience2026 · 0 citations
- Preventability of adverse drug reactions to anticancer drugs: insights from the database of the Regional Drug Information and Pharmacovigilance Center2026 · 0 citations
Journals in the same field
| Journal | Quartile | SJR | Summaries |
|---|---|---|---|
| Nature | Q1 | 19.00 | 1 |
| New England Journal of Medicine | Q1 | 18.00 | 29 |
| Physiological Reviews | Q1 | 11.00 | 2 |
| Science | Q1 | 10.00 | 3 |
| Blood | Q1 | 5.00 | 12 |
| European Heart Journal | Q1 | 5.00 | 1 |
| The Lancet Global Health | Q1 | 5.00 | 1 |
| Journal of Clinical Oncology | Q1 | 4.00 | 2 |
| Blood Cancer Journal | Q1 | 4.00 | 2 |
| Nature Communications | Q1 | 4.00 | 1 |
See every journal in the field →
Follow these journals on Pofolia
Pick your fields and new papers from their journals land in your feed every day with AI summaries. Free.
Start free